Angiotensin converting enzyme inhibitory activity and antioxidant activities of aqueous extract of combretum micranthum leaves
Table Of Contents
Chapter ONE
INTRODUCTION
- 1.1Introduction
- 1.2Background of Study
- 1.3Problem Statement
- 1.4Objective of Study
- 1.5Limitation of Study
- 1.6Scope of Study
- 1.7Significance of Study
- 1.8Structure of the Research
- 1.9Definition of Terms
Chapter TWO
LITERATURE REVIEW
- 2.1Overview of Angiotensin Converting Enzyme
- 2.2Importance of Angiotensin Converting Enzyme Inhibitory Activity
- 2.3Antioxidant Activities in Plant Extracts
- 2.4Combretum Micranthum Leaves: A Brief Description
- 2.5Previous Studies on Combretum Micranthum Leaves
- 2.6Studies on ACE Inhibitory Activity in Plant Extracts
- 2.7Studies on Antioxidant Activities of Plant Extracts
- 2.8Relationship Between ACE Inhibitory Activity and Antioxidant Activities
- 2.9Methods for Evaluating ACE Inhibitory Activity
- 2.10Methods for Evaluating Antioxidant Activities
Chapter THREE
RESEARCH METHODOLOGY
- 3.1Research Methodology Overview
- 3.2Selection of Combretum Micranthum Leaves
- 3.3Extraction Process for Aqueous Extract
- 3.4Evaluation of ACE Inhibitory Activity
- 3.5Evaluation of Antioxidant Activities
- 3.6Data Collection and Analysis
- 3.7Statistical Analysis Methods
- 3.8Ethical Considerations in Research
Chapter FOUR
DATA PRESENTATION AND ANALYSIS
- 4.1Presentation of Research Findings
- 4.2ACE Inhibitory Activity Results
- 4.3Antioxidant Activity Results
- 4.4Comparison of ACE Inhibitory and Antioxidant Activities
- 4.5Factors Influencing Activity Levels
- 4.6Discussion on the Significance of Findings
- 4.7Implications of the Results
- 4.8Future Research Recommendations
Chapter FIVE
SUMMARY, CONCLUSION AND RECOMMENDATIONS
- 5.1Conclusion and Summary
- 5.2Summary of Findings
- 5.3Contributions to the Field
- 5.4Limitations of the Study
- 5.5Recommendations for Further Research
- 5.6Final Thoughts
Project Abstract
Combretum micranthum is a medicinal plant widely used in traditional medicine for its various health benefits. This study aimed to investigate the angiotensin converting enzyme (ACE) inhibitory activity and antioxidant properties of the aqueous extract of Combretum micranthum leaves. The ACE inhibitory activity was determined using a colorimetric assay, while the antioxidant activities were assessed through various methods including DPPH radical scavenging assay, ferric reducing antioxidant power (FRAP) assay, and total phenolic content determination. The results revealed that the aqueous extract of Combretum micranthum leaves exhibited significant ACE inhibitory activity with an IC50 value of 0.32 mg/mL. This suggests the potential of the plant extract as a natural ACE inhibitor, which could be beneficial in managing hypertension and related cardiovascular conditions. Furthermore, the extract demonstrated strong antioxidant properties, as evidenced by its high DPPH radical scavenging activity, FRAP value, and total phenolic content. The DPPH radical scavenging assay showed that the extract had a dose-dependent scavenging effect on the free radicals, with an IC50 value of 0.45 mg/mL. The FRAP assay indicated the extract's ability to reduce ferric ions, reflecting its electron-donating capacity and potential antioxidant power. Additionally, the total phenolic content of the extract was found to be 56.7 mg gallic acid equivalent per gram of extract, indicating the presence of phenolic compounds that contribute to its antioxidant activity. Overall, the aqueous extract of Combretum micranthum leaves exhibited promising ACE inhibitory activity and potent antioxidant properties. The dual activities of ACE inhibition and antioxidant effects make this plant extract a valuable candidate for further development as a natural remedy for hypertension and oxidative stress-related conditions. Further studies are warranted to isolate and identify the bioactive compounds responsible for these activities and to elucidate the underlying mechanisms of action. The findings of this study contribute to the growing body of evidence supporting the therapeutic potential of Combretum micranthum in the management of cardiovascular diseases and oxidative stress.
Project Overview
<p>
</p><p><strong>1.0 INTRODUCTION</strong></p><p><strong>1.1 Background of the Study</strong></p><p>The word hypertension is defined as a persistence increase in systemic arterial blood pressure (Sembulingam and Sembuligam, 2006). Clinically, when the systolic pressure remains elevated above 140mmHg and diastolic pressure remains elevated above 90mmHg, it is considered as hypertension. The prevalence varies with age, race, education, occupation and many other variables (Benowitz, 2009). In Nigeria for example, the true incidence of hypertension remains unknown but its prevalence among male and female is estimated to be 11.2% with age adjusted figure of 9.3% (Nurudeen<em>et al.,</em> 2013). This translates into approximately 13.4 million Nigerians becoming hypertensive at the age of 15years and above, using the projected national population census figure of 120million (Akinkungbe, 1998). In fact, hypertension is reported to be next to malaria as most serious health problems in developing tropical countries (Agunwa, 1988).</p><p>The global dimension of hypertension is immense, as it ranks the most common cardiovascular ailment afflicting about one billion people in the world and causing roughly 7.1 million deaths annually (Brundtland, 2002). Hypertension is said to be the most common cardiovascular disease among Africans and congestive cardiac failure its commonest complication (Akinkungbe 1972, 1985). Earlier studies suggested that hypertension was rare in African population (Sharper <em>et al.,</em> 1969, Pobee<em>et al.,</em> 1977), however, epidemiological transition, urbanization, adoption of urban and foreign lifestyles and improved case findings, among others, have made hypertension more prevalent as shown in some studies (Cooper <em>et</em> <em>al., </em>1998). The last Nigerian National Non-communicable Disease Survey (NNCDS) conducted in 1997 reported 11.4% prevalence of adult hypertension, varying from 14.8% in urban to 9.8% in rural residences respectively. However, a report on Nigeria from the World</p>
<br><p></p>